Hemithorax Irradiation for High-Risk Chest Wall Sarcomas: Current Evidence, Clinical Practice and Future Directions.

Curr Treat Options Oncol · 2026 · PMC13190504 · PMID 42159630

Europe PMC DOI

hedged sentence

0.0200

closest p · 0.4× alpha

0.0200

boldest claim

The sentences

did not reach statistical significancep = 0.02actually significant

While the difference did not reach statistical significance, the improvement in EFS was attributed to a significant reduction in systemic relapses (22% vs. 39%, p = 0.02), particularly lung metastases (7.3% vs. 20.9%) [ 5 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.